Fixed-dose combination
Citric acid, Lactic acid, l- and Potassium bitartrate is a fixed-dose combination of an anti-coagulant and a calculi dissolution agent. It is available as vaginal gel. MedsAcross supplies Citric acid, Lactic acid, l- and Potassium bitartrate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
PHEXX is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception. PHEXX is a combination of lactic acid, citric acid, and potassium bitartrate indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception. Limitations of Use: PHEXX is not effective for the prevention of pregnancy when administered after intercourse.
Source: US FDA prescribing information
In in vitro studies, PHEXX produced a normal vaginal pH range (pH 3.5 – 4.5) in the presence of semen. In clinical studies, post-coital testing demonstrated pH <5 in the majority of subjects, and sperm motility reduction.
Source: US FDA prescribing information
Administer one pre-filled single-dose applicator of PHEXX (5 grams) vaginally immediately before (or up to one hour before) each episode of vaginal intercourse. May use during any part of the menstrual cycle
Source: US FDA prescribing information
Cystitis and Pyelonephritis: Avoid use in women with a history of recurrent UTI or urinary tract abnormalities Cystitis and Pyelonephritis Among 2804 subjects who received PHEXX in Studies 1 and 2, 0.36% (n=10) reported adverse reactions of cystitis, pyelonephritis, or other upper urinary tract infection (UTI). Of these, one case of pyelonephritis was considered serious and required hospitalization. Avoid use of PHEXX in females of reproductive potential with a history of recurrent urinary tract infection or urinary tract abnormalities.
Source: US FDA prescribing information
The following clinically significant adverse reactions are described elsewhere in the labeling: Cystitis and Pyelonephritis Most common adverse reactions (≥2%) were vulvovaginal burning sensation, vulvovaginal pruritus, vulvovaginal mycotic infection, urinary tract infection, vulvovaginal discomfort, bacterial vaginosis, vaginal discharge, genital discomfort, dysuria, and vulvovaginal pain.
Source: US FDA prescribing information
Store in the original foil pack at room temperature 20°C to 25°C (68°F to 77°F), excursion permitted between 15°C to 30°C (59°F to 86°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
2 presentations of Citric acid, Lactic acid, l- and Potassium bitartrate, sorted by availability.
| Medicine | Active ingredient | Manufacturer | Register | Availability |
|---|---|---|---|---|
| Phexx 50 mg/90 mg/20 mg per 5 g vaginal gelVaginal | Citric acid, Lactic acid, l- and Potassium bitartrate | Evofem | US FDA | Available on request |
| Phexxi 50 mg/90 mg/20 mg per 5 g vaginal gelVaginal | Citric acid, Lactic acid, l- and Potassium bitartrate | Evofem | US FDA | Available on request |
2 brand names across 1 markets.
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Not recorded | — |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 2 presentations of Citric acid, Lactic acid, l- and Potassium bitartrate and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 2 brand names for Citric acid, Lactic acid, l- and Potassium bitartrate, including Phexx, Phexxi.
No listed presentation of Citric acid, Lactic acid, l- and Potassium bitartrate is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.